What’s Driving Growth in the Blood Stream Infection Testing Market? Insights into Key Trends and Opportunities
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How has the blood stream infection testing market grown in recent years?
The market for blood stream infection testing has experienced significant expansion in the last few years. It is forecasted to increase from $7.59 billion in 2024 to $8.49 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this growth during the historic period include a surge in hospital-acquired infections, an increase in antimicrobial resistance, a growing elderly population, heightened healthcare spending, and a rise in chronic disease occurrence.
How is the blood stream infection testing market size expected to evolve during the forecast period?
The market size for blood stream infection testing is projected to witness a swift expansion in the upcoming years, inflating to $13.19 billion in 2029 with a compound annual growth rate (CAGR) of 11.7%. The anticipated growth during the forecast period can be credited to the escalating demand for expeditious diagnostic tests, increased acceptance of molecular diagnostics, heightened attention on personalized medicine, governmental endeavours in infection management, and growing presence of multi-drug-resistant pathogens. Key trends expected during the forecast period incorporate the escalating usage of AI in diagnostic instruments, merging of telemedicine with diagnostic amenities, increased interest in home-based testing kits, development of multiplex diagnostic platforms, and rising collaborations between diagnostic corporations and healthcare institutions.
Get your blood stream infection testing market report here!
Which key drivers are propelling the blood stream infection testing market’s growth?
The blood stream infection testing market is projected to grow, primarily driven by the escalating prevalence of infectious diseases. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, and parasites are seeing a significant spike. Several reasons contribute to this surge, including increased worldwide travel, urbanization, climate change, antibiotic resistance, and vaccination coverage gaps. Bloodstream infection testing is critical in diagnosing and identifying the pathogens causing severe diseases like sepsis, thus enabling a targeted and effective course of treatment. For example, the World Health Organization’s (WHO) World Malaria report published in December 2023 identified an increase in the number of malaria cases – from 244 million in 2021 to 249 million in 2022. However, the estimated death count fell slightly from 610,000 in 2021 to 608,000 in 2022. Consequently, the rise in infectious diseases prevalence is fuelling the growth of the blood stream infection testing market.
What are the market segments in the blood stream infection testing industry?
The blood stream infection testing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp
Which leading companies are shaping the growth of the blood stream infection testing market?
Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMÉRIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.
What key trends are currently impacting the blood stream infection testing market’s development?
Leading enterprises in the bloodstream infection testing market are emphasizing product innovation, with a specific focus on blood testing cartridges, in order to maintain market dominance. These cartridges, which are single-use devices for blood sample analysis in diagnostic tests, contain ready-to-go reagents and built-in sensors or microfluidic channels for detecting unique biomarkers, pathogens, or conditions in a small blood sample. For instance, Immunexpress Pty Ltd., an Australian molecular diagnostics firm, introduced the SeptiCyte RAPID cartridges in August 2022. These cartridges utilize undiluted ethylenediaminetetraacetic acid (EDTA) blood as a verified sample type, shown to correlate highly with other blood collection procedures through extensive multi-site European research. This innovation enhances the accuracy and effectiveness of sepsis diagnoses, paving the way for broader and faster clinical adoption, which could revolutionize patient care and reduce healthcare expenses.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20514
Which geographic areas are influencing the growth of the blood stream infection testing market?
North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Infection Control Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Control Supplies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Urinary Tract Infection Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
